How Inflammation Impinges on NAFLD: A Role for Kupffer Cells
Open accessThe DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most prevalent cause of liver disease worldwide and afflicts adults and children as currently associated with obesity and insulin resistance. Even though lately some advances have been made to elucidate the mechanism and causes of the disease much remains unknown about NAFLD. The aim of this paper is to discuss the present knowledge regarding the pathogenesis of the disease aiming at the initial steps of NAFLD development, when inflammation impinges on fat liver deposition. At this stage, the Kupffer cells attain a prominent role. This knowledge becomes subsequently relevant for the development of future diagnostic, prevention, and therapeutic options for the management of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several compounds bind to TLRs expressed in Kupffer cells and also in hepatic stellate cells, namely methylamine, volatile organic compounds and pathogen-associated molecular patterns, which include LPS, lipoteichoic acid, peptidoglycan, flagellin and unmethylated CpG DNA, and activate inflammatory signaling pathways like the NF-kB [298].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [298]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“Markedly, wild-type mice on chow diet when infused continuously with low-dose LPS developed hepatic steatosis, insulin resistance, and weight gain [54].”
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143 · cited 1×
“TNFα or TNFα receptor knockout obese mice have improved insulin sensitivity compared to wild-type controls [60].”
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664 · cited 1×
“In Europe and in the United States, it is estimated that 3 out of 10 adults developed NAFLD [1, 2].”
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 2×
“The overflow of free fatty acids (FFAs) coming from lipolysis of adipose tissue is the main contributor to hepatic steatosis [15, 16].”
Macrophage activation and polarization
Martinez, F. O. (2008) · Frontiers in Bioscience · doi:10.2741/2692 · Cited by 3,160 · cited 2×
“Dietary factors, such as fructose, may contribute to altered intestinal motility, bacterial overgrowth, and increased intestinal permeability which is also associated with NAFLD [67].”
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548 · cited 2×
“The initial view that considered steatosis as a primary hit and gutderived endotoxin as the second hit determining progression of the disease is now followed by a more complex model where many hits may act in parallel [40].”
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Research works printed but not linked: 1
- Pagliassoti M. Wei Y. Wang D. Saturated fatty acids induce cytotoxicity in hepatocytes via effects on the endoplasmic reticulum Obesity Research 2005 13 p. A31
Cited by
Ginwala, R., Bhavsar, R., Chigbu, D. G. I., Jain, P., & Khan, Z. K. (2019) · Antioxidants · doi:10.3390/antiox8020035 · Cited by 588
“Excessive accumulation of fat and the presence of circulating free fatty acids contribute to oxidative damage, immune system activation, and dysregulation of cytokine pathways through recognition by PRRs such as toll-like receptors (TLR)s, in particular, TLR4 [92].”
BackgroundInnate Immunity and Inflammation in NAFLD/NASH
Arrese, M., Cabrera, D., Kalergis, A. M., & Feldstein, A. E. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4049-x · Cited by 492
“This cell type derives from circulating monocytes and represents around 15% of the liver cells being the largest tissuespecific reservoir of macrophages in the body [45].”
PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets
Chen, H., Tan, H., Wan, J., Zeng, Y., Wang, J., Wang, H., & Lu, X. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108391 · Cited by 311
Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
Yan, T., Yan, N., Wang, P., Xia, Y., Hao, H., Wang, G., & Gonzalez, F. J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.11.017 · Cited by 224
Pathogenesis of nonalcoholic steatohepatitis
Liu, W., Baker, R. D., Bhatia, T., Zhu, L., & Baker, S. S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2161-x · Cited by 221
“In addition, Kupffer cells can also be activated by diacylglycerol, ceramide, cholesterol, oxidized lipoproteins, and engulfment of apoptotic hepatocytes [174, 189].”
Xu, F., Guo, M., Huang, W., Feng, L., Zhu, J., Luo, K., Gao, J., Zheng, B., Kong, L.-D., Pang, T., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101634 · Cited by 196
Kupffer Cell Metabolism and Function.
Nguyen‐Lefebvre, A. T., & Horuzsko, A. (2015) · PubMed · Cited by 241
Ohara, M., Ohnishi, S., Hosono, H., Yamamoto, K., Yuyama, K., Nakamura, H., Fu, Q., Maehara, O., Suda, G., & Sakamoto, N. (2018) · Stem Cells International · doi:10.1155/2018/3212643 · Cited by 145
“In the early stages of the disease, KCs expand rapidly and secrete cytokines and chemokines such as IL-1, TNF-α, MCP-1, and C-C motif chemokine ligand (CCL)5 [37], reflecting their involvement in the control of inflammatory responses in NASH and their major role in the recruitment of inflammatory cells in the liver [3…”
BackgroundAnti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice
Ham, J. R., Lee, H.-I., Choi, R., Sim, M., Seo, K., & Lee, M. (2016) · Food & Function · doi:10.1039/c5fo01329a · Cited by 140
Kwon, J., Lee, C., Heo, S., Kim, B., & Hyun, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-84761-1 · Cited by 139
Meneses, M. J., Silvestre, R. D., Sousa‐Lima, I., & Macedo, M. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164049 · Cited by 132
Self-citationDu, X., Wu, Z., Xu, Y., Liu, Y., Liu, W., Wang, T., Li, C., Zhang, C., Yi, F., Gao, L., et al. (2018) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0032-0 · Cited by 114
The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
JASIRWAN, C. O. M., LESMANA, C. R. A., HASAN, I., SULAIMAN, A. S., & GANI, R. A. (2019) · Bioscience of Microbiota, Food and Health · doi:10.12938/bmfh.18-032 · Cited by 106
“Both TNF-α and NF-κB are activated, and together they promote insulin resistance and are involved in liver inflammation [59].”
BackgroundZhou, Y. J., Ding, Y., Zhang, J.-L., Zhang, P., Wang, J.-Q., & Li, Z.-H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.035 · Cited by 105
Diehl, K. L., Vorac, J., Hofmann, K., Meiser, P., Unterweger, I. A., Kuerschner, L., Weighardt, H., Förster, I., & Thiele, C. (2020) · Cells · doi:10.3390/cells9102258 · Cited by 96
Ni, Y., Zhuge, F., Nagashimada, M., & Ota, T. (2016) · Nutrients · doi:10.3390/nu8070391 · Cited by 90
“During the early stages of the disease, hepatic macrophages expand rapidly and secrete cytokines and chemokines, such as IL-1β, TNF-α, MCP-1, and CCL5, contributing to paracrine activation of protective or apoptotic signaling pathways in hepatocytes, and the recruitment of other immune cells [70].”
BackgroundNon-alcoholic fatty liver disease (NAFLD) models in drug discovery
Cole, B. K., Feaver, R. E., Wamhoff, B. R., & Dash, A. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1410135 · Cited by 79
“During hepatic insult or metabolic fluctuations of lipids, these cells rapidly expand and secrete cytokines and chemokines (reviewed in Duarte et al. 2015 [77]).”
BackgroundExercise and diabetes: relevance and causes for response variability
Böhm, A., Weigert, C., Staiger, H., & Häring, H.-U. (2016) · Endocrine · doi:10.1007/s12020-015-0792-6 · Cited by 78
“This linkage between inflammation and diabetes was extensively shown in various organs, like adipose tissue [165], skeletal muscle [166], and liver [167].”
BackgroundPathogenicity and virulence of Hepatitis B virus
Chuang, Y.-C., Tsai, K.-N., & Ou, J. J. (2022) · Virulence · doi:10.1080/21505594.2022.2028483 · Cited by 95
“Kupffer cells comprise approximately 15% of the total liver cell population[456].”
BackgroundPan, Y., & Kong, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.020 · Cited by 78
The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Cha, J.-Y., Kim, D.-H., & Chun, K. (2018) · Laboratory Animal Research · doi:10.5625/lar.2018.34.4.133 · Cited by 78
Coelho, I., Duarte, N., Barros, A., Macedo, M. P., & Penha-Gonçalves, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.616044 · Cited by 70
“Macrophages play decisive roles in inflammatory and tissue repair responses during acute and chronic liver injury1–3 and in liver damage associated to metabolic disorders such as NAFLD4,5, type 2 diabetes and obesity6.”
BackgroundSelf-citationOxidative Stress and Redox Signaling in the Pathophysiology of Liver Diseases
Mooli, R. G. R., Mukhi, D., & Ramakrishnan, S. K. (2022) · Comprehensive physiology · doi:10.1002/cphy.c200021 · Cited by 152
Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH
Svegliati-Baroni, G., Patrício, B., Lioci, G., Macedo, M. P., & Gastaldelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165820 · Cited by 66
Self-citationGao, M., Zhao, W., Li, C., Xie, X., Li, M., Bi, Y., Fang, F., Du, Y., & Liu, X. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.078 · Cited by 67
Macrophages in nonalcoholic fatty liver disease: a role model of pathogenic immunometabolism
Krenkel, O., & Tacke, F. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1604480 · Cited by 66
Key Players of Hepatic Fibrosis
Dawood, R. M., El-Meguid, M. A., Salum, G. M., & Awady, M. K. E. (2020) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2020.0059 · Cited by 73
Suurmond, C. E., Lasli, S., van den Dolder, F. W., Ung, A., Kim, H., Bandaru, P., Lee, K., Cho, H., Ahadian, S., Ashammakhi, N., et al. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201901379 · Cited by 61
Dynamic plasticity of macrophage functions in diseased liver
Ritz, T., Krenkel, O., & Tacke, F. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2017.12.007 · Cited by 58
Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target
Chen, C., & Lin, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710055 · Cited by 66
“In addition to hepatocytes, non-parenchymal cells (including KCs and HSCs) and adipose tissue are closely related to the pathogenesis of MAFLD [9,10].”
BackgroundTeratani, T., Tomita, K., Furuhashi, H., Sugihara, N., Higashiyama, M., Nishikawa, M., Irie, R., Takajo, T., Wada, A., Horiuchi, K., et al. (2019) · Hepatology Communications · doi:10.1002/hep4.1383 · Cited by 56
Tang, R., Li, R., Li, H., Ma, X., Du, P., Yu, X.-Y., Ren, L., Wang, L., & Zheng, W. (2021) · ACS Nano · doi:10.1021/acsnano.1c02158 · Cited by 61
Hazrati, A., Malekpour, K., Soudi, S., & Hashemi, S. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.865888 · Cited by 48
“2 Kpffer Cells (KCs) Kupffer cells make up 20% of non-parenchymal cells in the liver and are located around the portal vein (80).”
BackgroundGuo, J., Fang, W., Sun, L., Lu, Y., Dou, L., Huang, X., Sun, M., Pang, C., Qu, J. T., Liu, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9183 · Cited by 49
Musazadeh, V., Dehghan, P., & Khoshbaten, M. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002297 · Cited by 45
Chen, H.-J., Hao-yu, Y. A. N. G., Hsueh, K.-C., Shen, C., Chen, R.-Y., Yu, H., & Wang, T.-L. (2018) · Medicine · doi:10.1097/md.0000000000012835 · Cited by 48
“However, osteocalcin was decreased in patients with NAFLD.”
BackgroundInfluentialYu, L., Zhao, Y., & Zhao, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1240820 · Cited by 40
Co-administration effects of aqueous extract of turnip leaf and metformin in diabetic rats
Taheri, M. M. H., Fard, M. H., Doostabadi, M., Moodi, H., Vazifeshenas-Darmiyan, K., & Hosseini, M. (2017) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2017.05.010 · Cited by 41
Dietary and commercialized fructose: Sweet or sour?
Yerlikaya, A., Dağel, T., King, C., Kuwabara, M., Lanaspa, M. A., Andrés-Hernando, A., Covic, A. C., Manitius, J., Sag, A. A., & Kanbay, M. (2017) · International Urology and Nephrology · doi:10.1007/s11255-017-1544-8 · Cited by 39
Zhang, R., Xu, D., Zhang, Y., Wang, R., Yang, N., Lou, Y., Zhao, H., Aa, J., Wang, G., & Xie, Y. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000438 · Cited by 31
“Previous research investigated how cytokines regulate P450s through NF-κB under LPS-induced inflammation (Morgan et al., 2002; Wree et al., 2014).”
BackgroundInfluentialAssociation between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis
Song, W., Yoo, S. H., Jang, J., Baik, S. J., Lee, B. K., Lee, H. W., & Park, J. S. (2022) · Gut and Liver · doi:10.5009/gnl220041 · Cited by 33
“35,36 Wijarnpreecha et al. 9 also explained that the mechanism underlying these relationships is primarily due to inter-organ interconnections by insulin resistance, chronic inflammation, oxidative stress, and secretion of cytokines.”
Mild Methylenetetrahydrofolate Reductase Deficiency Alters Inflammatory and Lipid Pathways in Liver
Leclerc, D., Christensen, K. E., Cauvi, O., Yang, E., Fournelle, F., Bahous, R. H., Malysheva, O., Deng, L.-Y., Wu, Q. H., Zhou, Z., et al. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801001 · Cited by 30
Kakinuma, Y., Kimura, T., & Watanabe, Y. (2017) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2017/2896809 · Cited by 31
The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Shouhed, D., Steggerda, J. A., Burch, M. A., & Noureddin, M. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1355731 · Cited by 30
“KC activation may occur via NOD-like receptors (NLRs) and Toll-like receptors (TLRs) or independently by diacylglycerol (DAG), cholesterol, or engulfment of apoptotic hepatocytes [31].”
BackgroundGao, J., Song, J., Du, ., & Mao, X. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.01.027 · Cited by 31
Zhong, L., Huang, L., Xue, Q., Liu, C., Xu, K., Shen, W., & Deng, L. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28456 · Cited by 27
“Usually, KCs are hepatic sinusoids resident and principally nonmigratory phagocytes, serving as sentinels for liver homeostasis, while the recruited bone marrow–derived macrophages mainly originate from monocytes, both of them contributes to mediate hepatic inflammation.(2,8) During the early stage of NAFLD, the hepat…”
BackgroundRho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases
Sousa‐Lima, I., Kim, H. J., Jones, J. G., & Kim, Y. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0197 · Cited by 28
“Activated Kupffer cells induce numerous inflammatory chemokines and cytokines secretion, resulting in detrimental effects on hepatic function, inflammation, and insulin resistance [18,23].”
BackgroundInnate Immune System in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
Ma, D. W., Ha, J., Yoon, K., Kang, I., Choi, T. G., & Kim, S. S. (2023) · Nutrients · doi:10.3390/nu15092068 · Cited by 27
“They constitute approximately 15 percent of hepatic cells [106].”
BackgroundJiang, J., Messner, S., Kelm, J. M., van Herwijnen, M. H. M., Jennen, D. G. J., Kleinjans, J. C. S., & de Kok, T. M. C. M. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.05.004 · Cited by 25
Xia, Y., Zhang, Q., Liu, L., Meng, G., Wu, H., Bao, X., Gu, Y., Sun, S., Wang, X., Zhou, M., et al. (2019) · Nutrition · doi:10.1016/j.nut.2019.110562 · Cited by 26
Anti-obesity and anti-hepatosteatosis effects of dietary scopoletin in high-fat diet fed mice
Ham, J. R., Lee, H.-I., Choi, R., Sim, M., Choi, M., Kwon, E., Yun, K. W., Kim, M., & Lee, M. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.06.026 · Cited by 23
Immunological dynamics in MASH: from landscape analysis to therapeutic intervention
Rabiu, L., Zhang, P., Afolabi, L. O., Saliu, M. A., Dabai, S. M., Suleiman, R. B., Gidado, K. I., Ige, M. A., Ibrahim, A., Zhang, G., et al. (2024) · Journal of Gastroenterology · doi:10.1007/s00535-024-02157-0 · Cited by 26
“They are derived from monocytes in circulation and are essential in stopping the transfer of germs or their byproducts from the portal vein to the surrounding tissues [41].”
Insights into Macrophage/Monocyte-Endothelial Cell Crosstalk in the Liver: A Role for Trem-2
Coelho, I., Duarte, N., Macedo, M. P., & Penha‐Gonçalves, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061248 · Cited by 24
“The hallmark of NAFLD is an excess of fatty acids and lipids in the liver that results in lipotoxicity and hepatocyte injury initiating tissue inflammation [4].”
BackgroundSelf-citationCellular heterogeneity and plasticity during NAFLD progression
Park, H., Choi, J., Kim, H.-M., Yang, D.-Y., An, T. H., Lee, E., Han, B., Lee, S. C., Kim, W. K., Bae, K., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1221669 · Cited by 24
“, 2021); the release and activation of proinflammatory cytokines from Kupffer cells or adipokines from adipocytes (Duarte et al., 2015); and activation of HSC into collagen type I-producing myofibroblasts that form scar tissue (Higashi et al.”
BackgroundImmunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications
Guo, Z., Wu, Q., Xie, P., Wang, J., & Lv, W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1336493 · Cited by 31
Engineered Hydrogels for Organoid Models of Human Nonalcoholic Fatty Liver Disease
Liu, Y., Gilchrist, A. E., Johansson, P. K., Guan, Y., Deras, J. D., Liu, Y., Ceva, S., Huang, M. S., Navarro, R. S., Enejder, A. M. K., et al. (2025) · Advanced Science · doi:10.1002/advs.202417332 · Cited by 29
The Biological Function of Kupffer Cells in Liver Disease
Ma, Y., Yang, M., He, Z., Wei, Q., & Li, J. (2017) · InTech eBooks · doi:10.5772/67673 · Cited by 25
“Kupffer cells (KCs), as the largest population mononuclear phagocytes in the body, account for 80–90% of the total number of natural macrophages and 20% of the liver nonparenchymal cells [1].”
BackgroundZhong, L., Yuan, J., Huang, L., Li, S., & Deng, L. (2020) · BioMed Research International · doi:10.1155/2020/6953421 · Cited by 23
Afshari, H., Noori, S., & Zarghi, A. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02520-7 · Cited by 22
“Additionally, studies have shown that inflammatory markers, such as interleukin 6 (IL-6) and tumor necrosis factor (TNF-α), play a critical role in initiating and escalating hepatic inflammation in NAFLD (Arrese et al. 2016; Duarte et al. 2015).”
BackgroundChen, N., Shan, Q., Qi, Y., Liu, W., Tan, X., & Gu, J. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.124747 · Cited by 22
Kato, H., Asano, Y., Ito, M., Arakawa, S., Shimura, M., Koike, D., Hayashi, C., Kamio, K., Kawai, T., & Horiguchi, A. (2022) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12593 · Cited by 18
The EP3 Receptor/Gz Signaling Axis as a Therapeutic Target for Diabetes and Cardiovascular Disease
Schaid, M. D., Wisinski, J. A., & Kimple, M. E. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0097-1 · Cited by 16
“In this state, hepatic tissues are incapable of properly managing glucose homeostasis through insulin regulatory mechanisms that halt gluconeogenesis and induce glycogen storage, exacerbating hyperglycemia (46,47).”
Zuo, G., Li, M.-H., Guo, X., Wang, L., Yao, Y., Huang, J., Liu, Z., & Lin, Y. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116207 · Cited by 21
Attia, A. A., Hamad, H. A., Fawzy, M., & Saleh, S. R. (2023) · Molecules · doi:10.3390/molecules28114302 · Cited by 18
“In the liver tissue, the Kupffer cells constitute approximately 20% of all hepatic cells [108].”
BackgroundAfshari, H., Noori, S., & Zarghi, A. (2023) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-136952 · Cited by 19
“Furthermore, investigations have uncovered that inflammatory indicators like interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) significantly impact the initiation and progression of NAFLD (20, 21).”
BackgroundNeves, C., Rodrigues, T., Sereno, J., Simões, C. S. O., Castelhano, J., Goncalves, J., Bento, G., Goncalves, S. I., Seiça, R. M. F., Domingues, M. R., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6362910 · Cited by 18
“ectopic nonesterified fatty acids are known to be a trigger to inflammation and insulin resistance [2, 36].”
BackgroundAnti-inflammatory effects of Sarcopoterium spinosum extract
Rozenberg, K., Wollman, A., Ben‐Shachar, M., Argaev-Frenkel, L., & Rosenzweig, T. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112391 · Cited by 15
Jeon, H., Yang, D., Lee, N. H., Ahn, M., & Kim, G. (2020) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2020.25.4.408 · Cited by 15
“…(Esser et al., 2014; Shay et al., 2015), atherosclerosis (Libby et al., 2002), and nonalcoholic fatty liver disease (NAFLD), while inflammatory cells, such as monocytes and macrophages, can produce a large repertoire of cytokines and induce pathogenic changes in tissues (Duarte et al., 2015).”
BackgroundPolyák, A., Bankstahl, J. P., Besecke, K. F. W., Hozsa, C., Triebert, W., Pannem, R., Manstein, F., Borcholte, T., Furch, M., Zweigerdt, R., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071097 · Cited by 12
“Since the liver’s Kupffer cells comprise 80–90% of all macrophages, thus constituting the body’s largest macrophage population [17,18], the liver’s macrophage pool is thus presumed to be less saturated than the splenic macrophage subsets.”
BackgroundPidwill, G. R., Pyrah, J. F., Sutton, J. A. F., Best, A., Renshaw, S. A., & Foster, S. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-27928-2 · Cited by 14
Kenneson, A., & Funderburk, J. S. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.11.035 · Cited by 12
Barrientos‐Riosalido, A., Real, M., Bertran, L., Aguilar, C., Martínez, S., Parada, D., Vives, M., Sabench, F., Riesco, D., Castillo, D. D., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021324 · Cited by 12
“During NAFLD development, multiple cellular interactions occur in hepatic tissue involving hepatocytes, hepatic stellate cells (HSCs), and macrophages or Kupffer cells (KCs) [9,10].”
BackgroundExtracellular vesicle‐mediated protein delivery to the liver
Ilahibaks, N. F., Roefs, M. T., Brans, M. A. D., Blok, C. S., de Jager, S. C. A., Schiffelers, R. M., Vader, P., Lei, Z., & Sluijter, J. P. G. (2023) · Journal of Extracellular Biology · doi:10.1002/jex2.97 · Cited by 12
“Kupffer cells, the body’s primary population of mononuclear phagocytes, constitute between 80% and 90% of all natural macrophages and 20% of the nonparenchymal cells in the liver (Duarte et al., 2015).”
BackgroundHee, S., Chang, Y., Su, L., Chen, I., Jeng, Y., Hsieh, M.-L., Chang, Y.-C., Li, F., Liao, D., Chen, S.-M., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107997 · Cited by 11
Extracellular Vesicles in Pathogenesis and Treatment of Metabolic Associated Fatty Liver Disease
Sun, J., Zhang, D., & Li, Y. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.909518 · Cited by 14
“Previous studies revealed that HFD and free fatty acids (FFAs) could activate KCs in vivo and in vitro (Xue et al., 2014; Duarte et al., 2015).”
BackgroundLi, T., Gong, H., Zhan, B., & Mao, X. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14045 · Cited by 14
Adak, M., Das, D., Niyogi, S., Challa, N. L., Ray, D., & Chakrabarti, P. (2018) · The FASEB Journal · doi:10.1096/fj.201800190 · Cited by 12
“Heterogeneity in liver macrophages, including those arising from circulating monocytes recruited via distinct chemokine signals (RHM) and the self-renewing embryoderived tissue-resident macrophages (KCs), having distinct cytokine and chemokine expression profiles, are implicated in obesity-associated hepatic inflammat…”
BackgroundHepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis
Kholodenko, I. V., & Yarygin, K. N. (2023) · Biomedicines · doi:10.3390/biomedicines11113056 · Cited by 16
Immune function of nonparenchymal liver cells
Xing, X., Wu, H., Feng, H., & Yuan, Z. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15018524 · Cited by 10
“It is the largest natural macrophage population in the human body, accounting for 80-90% of the total number of natural macrophages and 20% of the liver nonparenchymal cells (Duarte et al., 2015).”
BackgroundZeng, Y., Huang, X., Ma, Y., Di, X., Zhao, L., Wang, H., & Wei, X. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110018 · Cited by 9
Duarte, N., Coelho, I., Holovanchuk, D., Almeida, J. I., Penha‐Gonçalves, C., & Macedo, M. P. (2018) · Hepatology Communications · doi:10.1002/hep4.1225 · Cited by 10
“(13) Kupffer cells (KCs) are critical players in maintaining liver homeostasis and responsiveness to liver insults,(14) triggering both local responses and recruiting hematopoietic cells that participate in liver inflammatory and tissue repair responses.(15) Protection from liver steatosis and slower progression of no…”
BackgroundSelf-citationFukushima, H., Kono, H., Hirayama, K., Akazawa, Y., Nakata, Y., Wakana, H., & Fujii, H. (2020) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s248635 · Cited by 9
Ma, C., Wang, C., Zhang, Y., Zhou, H., & Li, Y. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467215666211217120448 · Cited by 8
Paying the Iron Price: Liver Iron Homeostasis and Metabolic Disease
Ameka, M., & Hasty, A. H. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210039 · Cited by 18
Sharma, S., Gali, S., Kundu, A. B., Park, J. H., Js, K., & Kim, H. S. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.97304 · Cited by 9
“HFD-induced IKK-β activation triggers NF-κB activation and results in a subsequent increase in inflammatory mediator production including TNFα, IL-6, and IL-1β [43].”
BackgroundAntunes, M. M., Godoy, G., Curi, R., Visentainer, J. V., & Bazotte, R. B. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0107 · Cited by 8
“48,49 The n-3 PUFAs are known to regulate the expression of genes involved in lipogenesis.”
Johnson, R., Shabalala, S. C., Mabasa, L., Kotzé-Hörstmann, L. M., Sangweni, N. F., Ramharack, P., Sharma, J. R., Pheiffer, C., Arowolo, A., & Gijsen, H. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-02001-2 · Cited by 9
“At a molecular level, the demonstrated upregulation of various pathways associated with DNL, inflammation, and insulin resistance was consistent with findings described elsewhere 11,14,15 .”
Fikry, H., Saleh, L. A., Sadek, D. R., & Abd-Alkhalek, H. A. (2024) · Cell and Tissue Research · doi:10.1007/s00441-024-03927-1 · Cited by 8
“When LPS binds to its receptors on the surface of Kupffer cells, pro-inflammatory cytokines are secreted and produced, which attract T and B lymphocytes as well as other leukocytes (Duarte et al. 2015).”
Does iron overload in metabolic syndrome affect macrophage profile? A case control study
Lahaye, C., Gladine, C., Pereira, B., Berger, J., Chinetti, G., Lainé, F., Mazur, A., & Ruivard, M. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126786 · Cited by 9
Nooijer, A. D., Vreugdenhil, A. C. E., Karnebeek, K., van Hasselt, P. M., & Fuchs, S. A. (2019) · GastroHep · doi:10.1002/ygh2.354 · Cited by 11
Yuan, Y., Naito, H., Kitamori, K., Hashimoto, S., Asano, T., & Nakajima, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243846 · Cited by 6
“HSCs are the major ECM-producing cells [12], whereas ECM proteolysis is regulated by MMPs, a group of zinc-dependent endopeptidases, and their inhibitor as well as the TIMP1, which is expressed by activated HSCs [13,14].”
BackgroundNonalcoholic Fatty Liver Disease
Bergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_9 · Cited by 6
Proteomic Profiling of Plasma- and Gut-Derived Extracellular Vesicles in Obesity
Baptista Pereira, P., Torrejón, E., Ferreira, I., Carvalho, A. S., Teshima, A., Sousa-Lima, I., Beck, H. C., Costa-Silva, B., Matthiesen, R., Macedo, M. P., et al. (2024) · Nutrients · doi:10.3390/nu16050736 · Cited by 6
“It is worth noting that the number of small EVs is elevated in the circulation of patients with insulin resistance [36] and in individuals with T2D [37].”
BackgroundSelf-citationZhang, S., Meng, G., Zhang, Q., Liu, L., Yao, Z., Wu, H., Gu, Y., Wang, Y., Zhang, T., Wang, X., et al. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab163 · Cited by 4
Jiayao, Y., Dongqing, T., Wei, M., Song, L., Yan, L., Shu, L., Zhang, S., Chenyu, L. I., & Du, N. (2022) · PubMed · doi:10.19852/j.cnki.jtcm.2022.05.009 · Cited by 4
Hu, Y., Zhang, T., Song, W., Peng, Z., Zhu, Y., Huang, Y. C., Li, X., Zhang, Z., Tang, M., & Yang, W. (2023) · Public Health Nutrition · doi:10.1017/s1368980023001970 · Cited by 4
Kupffer Cell and Hepatocyte Isolation from a Single Mouse Liver by Gradient Centrifugation
Oses, C., & Aouadi, M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0704-6_1 · Cited by 4
Yan, R., Choi, V. W. W., Hartono, T., Tse, I. M. Y., Tse, M. C. L., Zhou, Y., Xu, J., Sit, W. H., Wan, J. M. F., Li, E. T. S., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1076073 · Cited by 4
“The study by Bouwman et al. (21) also showed that partial or complete replacement of glucose with fructose did not lead to overeating and weight gain in mice on a moderately high-fat diet, and high fructose intake at up to 30% daily kcal did not lead to overeating and weight gain in healthy subjects compared to contro…”
BackgroundInfluentialDu, J., Cao, X., Diao, J., Zhang, Q., Peng, C. X., Li, J., & Xiao, X. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2017.12.008 · Cited by 3
“The inconsistencies in HFD-induced steatosis and NASH depend on animal species and strain, the dietary fat content, and the duration of treatment.15,16 By contrast, MCD-induced hepatic steatosis and NASH is recognized as one of the best-studied animal models of NAFLD.17e20 Rodents fed with MCD diets typically lose wei…”
BackgroundInfluentialOno, M., Watari, S., Nishizawa-Higashi, M., Konishi, T., Takahashi, Y., Saeki, H., & Joe, G. (2023) · Food Chemistry Molecular Sciences · doi:10.1016/j.fochms.2023.100165 · Cited by 3
Metadata
- Authors
- Duarte, N., Coelho, I. C., Patarrão, R. S., Almeida, J. I., Penha-Gonçalves, C., & Macedo, M. P.
- Affiliations
- Instituto Gulbenkian de Ciência (PT)
- Instituto Gulbenkian de Ciência (IGC), Rua da Quinta Grande 6, 2780-156 Oeiras, Portugal
- Associacao Protectora dos Diabeticos de Portugal (PT)
- Corresponding author
- Macedo, M. Paula
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-11
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4450298
- OpenAlex
- W1483567609
- Cited by
- 120
- References
- 86
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 16 · 2022: 17 · 2021: 14 · 2020: 13 · 2019: 16 · 2018: 10 · 2017: 11 · 2016: 8 · 2015: 2
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Fundação para a Ciência e a Tecnologia (PTDC/DTP-EPI/0207/2012, PTDC/BIM-MET/0486/2012)
- Portuguese Diabetes Society (PTDC/DTP-EPI/0207/2012, PTDC/BIM-MET/0486/2012)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- non-alcoholic fatty liver disease, Kupffer cells, liver inflammation, pathogenesis, hepatic steatosis, obesity, insulin resistance, macrophages
- MeSH terms
- Humans, Inflammation, Insulin Resistance, Kupffer Cells, Liver, Obesity, Risk Factors, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.